INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H951. A total of 6 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $527,000 | -75.6% | 105,600 | -54.7% | 0.00% | -100.0% |
| Q2 2021 | $2,163,000 | -40.4% | 233,300 | -40.4% | 0.00% | -40.0% |
| Q1 2021 | $3,631,000 | +18.7% | 391,300 | +13.3% | 0.01% | +25.0% |
| Q4 2020 | $3,058,000 | -54.2% | 345,500 | -40.0% | 0.00% | -63.6% |
| Q3 2020 | $6,676,000 | -15.3% | 575,500 | +96.8% | 0.01% | -31.2% |
| Q2 2020 | $7,880,000 | – | 292,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 255,000 | $441,000 | 0.00% |
| SIMPLEX TRADING, LLC | 42,200 | $73,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 21,100 | $37,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 164,300 | $284,000 | 0.00% |